PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.10%
Revenue growth above 1.5x RUN's 0.06%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
15.31%
Gross profit growth under 50% of RUN's 54.80%. Michael Burry would be concerned about a severe competitive disadvantage.
44.28%
EBIT growth above 1.5x RUN's 9.55%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
23.57%
Operating income growth above 1.5x RUN's 9.55%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
42.88%
Net income growth under 50% of RUN's 116.52%. Michael Burry would suspect the firm is falling well behind a key competitor.
34.48%
EPS growth under 50% of RUN's 116.56%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
34.48%
Diluted EPS growth under 50% of RUN's 115.92%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.29%
Share reduction more than 1.5x RUN's 0.68%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.29%
Diluted share reduction more than 1.5x RUN's 3.40%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
87.22%
OCF growth above 1.5x RUN's 53.98%. David Dodd would confirm a clear edge in underlying cash generation.
77.66%
FCF growth above 1.5x RUN's 4.97%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-44.47%
Negative 10Y revenue/share CAGR while RUN stands at 316.98%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-16.93%
Negative 5Y CAGR while RUN stands at 75.52%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
27.52%
3Y revenue/share CAGR under 50% of RUN's 81.26%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
81.97%
Positive long-term OCF/share growth while RUN is negative. John Neff would see a structural advantage in sustained cash generation.
88.61%
Positive OCF/share growth while RUN is negative. John Neff might see a comparative advantage in operational cash viability.
-181.21%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-210.21%
Negative 10Y net income/share CAGR while RUN is at 218.14%. Joel Greenblatt sees a major red flag in long-term profit erosion.
94.38%
Below 50% of RUN's 279.74%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-256.41%
Negative 3Y CAGR while RUN is 327.75%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-65.63%
Negative equity/share CAGR over 10 years while RUN stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
1001.41%
5Y equity/share CAGR above 1.5x RUN's 249.13%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
1362.76%
3Y equity/share CAGR above 1.5x RUN's 313.60%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.28%
Our AR growth while RUN is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
11.05%
We show growth while RUN is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
5.45%
Asset growth 1.25-1.5x RUN's 3.86%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
-5.37%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
22.31%
Debt growth far above RUN's 7.20%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-10.20%
Our R&D shrinks while RUN invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-8.99%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.